Here are the core points to remember: Cancer Risk: While rodent studies showed an increase in rare thyroid tumours, large-scale human studies (including the 2022 Hu et al
24 Limitations and future directions Despite the promising results, several limitations should be acknowledged
Ozempic represents a promising advancement in weight loss peptide therapy, offering a new avenue of treatment for those struggling with weight management Tirzepatide peptide - Mounjaro, Zepbound Tirzepatide is a novel peptide that has shown significant promise in the field of weight loss peptide therapy
Patients must follow Novo Nordisk's titration schedule, which typically advances from 0.25 mg weekly and increases every four weeks until reaching the target maintenance dose
Afshar H, Roohafza H, Mohammad-Beigi H, Haghighi M, Jahangard L, Shokouh P, et al